Associate Professor | Director of Biocomputing and Bioinformatics Core in Emory-Georgia Tech Center of Cancer Nanotechnology Excellence
Dr. Wang’s primary research interest is in biomedical and health informatics for systems medicine, with the goal to accelerate and enable the discovery, development, and translation in modern biology, medicine, and healthcare. She has been publishing in journals such as Annals of Biomedical Eng, BMC Bioinformatics, Trends in Biotechnology, Nature Protocols, Proceedings of National Academy of Sciences, Annual Review of Medicine, The Pharmacogenomics Journal, Nature Biotechnology, and Genome Biology etc. Her team has developed multiple informatics software systems. Among these, caCORRECT and omniBiomarker have been certified by NCI caBIG as silver-level compatible. During 2005-2010, Dr. Wang has served as the director of Bioinformatics and Biocomputing Core in NCI sponsored Emory-Georgia Tech Center of Cancer Nanotechnology Excellence. In addition, she has played an active role in working groups of National Cancer Institute (NCI/NIH) cancer Biomedical Informatics Grid (caBIG) on nanoinformatics, and FDA-led Microarray Quality Control Consortium (MAQC) on investigating regulatory guideline for biomarker. Currently, she serves as co-chair of Information Technology for Health (ITH) Technical Committee (TC) in IEEE EMBS.
Dr. Wang received Distinguished Cancer Scholar Award from Georgia Cancer Coalition in 2004, an Outstanding Undergraduate Research Faculty Mentor Award from Georgia Tech in 2005, and an Outstanding Service Award from IEEE BIBE in 2007. Dr. Wang received Ph.D.EE, multidisciplinary MS degrees (EE, Applied Math, and CS) from Georgia Institute of Technology in USA, and BEng from Tsinghua University in China. In addition, Dr. Wang has several years of industrial R&D experience in the former AT&T Bell Labs, Intel Architecture Labs, Hughes Research Labs, Lucent Technologies Bell Labs, and Agere Systems.